Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2005
Gefitinib-responsive EGFR-positive colorectal cancers have different proteome profiles from non-responsive cell lines
Judith Loeffler-Ragg, Sergej Skvortsov, Bettina Sarg, et al.
Journal of Radiation Research
|
July 1, 2005
Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells
Ira Skvortsova, Bela-Andre Popper, Sergej Skvortsov, et al.
Radiology and Oncology
|
May 3, 2021
Simvastatin is effective in killing the radioresistant breast carcinoma cells
Bertram Aschenbrenner, Giulia Negro, Dragana Savic, et al.
Molecular Cancer Therapeutics
|
January 7, 2005
Different proteome pattern of epidermal growth factor receptor-positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment
Sergej Skvortsov, Bettina Sarg, Judith Loeffler-Ragg, et al.
Cancers
|
July 29, 2023
Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma
Julian Mangesius, Katharina Hörmandinger, Robert Jäger, et al.
Cells
|
January 21, 2023
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
Dragana Savic, Teresa Bernadette Steinbichler, Julia Ingruber, et al.
Plos One
|
July 18, 2013
Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis
Kathrin Eller, Andrea Schroll, Miriam Banas, et al.
Cancer Research
|
May 13, 2010
E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer
Daniel Reimer, Michael Hubalek, Svenja Riedle, et al.
Proteomics
|
September 30, 2008
Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells
Ira Skvortsova, Sergej Skvortsov, Taras Stasyk, et al.
Molecular Cancer Therapeutics
|
June 19, 2007
Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-kappaB expression and proteasome activation in head and neck squamous carcinoma cell lines
Sergej Skvortsov, Ira Skvortsova, Taras Stasyk, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2005
Gefitinib-responsive EGFR-positive colorectal cancers have different proteome profiles from non-responsive cell lines
Judith Loeffler-Ragg, Sergej Skvortsov, Bettina Sarg, et al.
Journal of Radiation Research
|
July 1, 2005
Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells
Ira Skvortsova, Bela-Andre Popper, Sergej Skvortsov, et al.
Radiology and Oncology
|
May 3, 2021
Simvastatin is effective in killing the radioresistant breast carcinoma cells
Bertram Aschenbrenner, Giulia Negro, Dragana Savic, et al.
Molecular Cancer Therapeutics
|
January 7, 2005
Different proteome pattern of epidermal growth factor receptor-positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment
Sergej Skvortsov, Bettina Sarg, Judith Loeffler-Ragg, et al.
Cancers
|
July 29, 2023
Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma
Julian Mangesius, Katharina Hörmandinger, Robert Jäger, et al.
Cells
|
January 21, 2023
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
Dragana Savic, Teresa Bernadette Steinbichler, Julia Ingruber, et al.
Plos One
|
July 18, 2013
Lipocalin-2 expressed in innate immune cells is an endogenous inhibitor of inflammation in murine nephrotoxic serum nephritis
Kathrin Eller, Andrea Schroll, Miriam Banas, et al.
Cancer Research
|
May 13, 2010
E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer
Daniel Reimer, Michael Hubalek, Svenja Riedle, et al.
Proteomics
|
September 30, 2008
Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells
Ira Skvortsova, Sergej Skvortsov, Taras Stasyk, et al.
Molecular Cancer Therapeutics
|
June 19, 2007
Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-kappaB expression and proteasome activation in head and neck squamous carcinoma cell lines
Sergej Skvortsov, Ira Skvortsova, Taras Stasyk, et al.
Page
of 4